| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.2217/PGS.11.68 |
| P698 | PubMed publication ID | 21919606 |
| P2093 | author name string | Kazutaka Ikeda | |
| Shinya Kasai | |||
| P2860 | cites work | Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment | Q24318653 |
| Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction | Q24320057 | ||
| Genetic susceptibility to heroin addiction: a candidate gene association study | Q24634090 | ||
| An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study | Q24645469 | ||
| Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm | Q28250678 | ||
| Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia | Q28585437 | ||
| Drug abuse: hedonic homeostatic dysregulation | Q29615904 | ||
| Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers | Q30486679 | ||
| The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells | Q30821241 | ||
| A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling | Q31532158 | ||
| Characterizing exons 11 and 1 promoters of the mu opioid receptor (Oprm) gene in transgenic mice | Q33263445 | ||
| Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians | Q33330500 | ||
| Expansion of the human mu-opioid receptor gene architecture: novel functional variants | Q33395205 | ||
| The interaction of reward genes with environmental factors in contribution to alcoholism in mexican americans | Q33598156 | ||
| The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses | Q33679584 | ||
| Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes | Q33797971 | ||
| Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder | Q33913645 | ||
| Pharmacokinetic-pharmacodynamic modeling of morphine-6-glucuronide-induced analgesia in healthy volunteers: absence of sex differences | Q44706338 | ||
| Predicting the effect of naltrexone and acamprosate in alcohol-dependent patients using genetic indicators. | Q45971153 | ||
| Relatively strong automatic appetitive action-tendencies in male carriers of the OPRM1 G-allele. | Q46240029 | ||
| Clinical response to morphine in cancer patients and genetic variation in candidate genes | Q46653217 | ||
| Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease. | Q46910776 | ||
| Unique behavioural phenotypes of recombinant-inbred CXBK mice: partial deficiency of sensitivity to mu- and kappa-agonists | Q48094995 | ||
| Family history of alcoholism and hypothalamic opioidergic activity | Q48323999 | ||
| Analgesic requirements after major abdominal surgery are associated with OPRM1 gene polymorphism genotype and haplotype | Q48463805 | ||
| Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence. | Q50888473 | ||
| Association of the functional A118G polymorphism of OPRM1 in diabetic patients with foot ulcer pain. | Q51756681 | ||
| Genetic moderators of naltrexone's effects on alcohol cue reactivity. | Q51791744 | ||
| Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action. | Q51955912 | ||
| Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. | Q52007326 | ||
| Environmental and genetic factors associated with morphine response in the postoperative period | Q57611840 | ||
| Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers | Q34180425 | ||
| A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. | Q34573827 | ||
| Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample | Q34614468 | ||
| Exploring the opioid system by gene knockout | Q34641459 | ||
| Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers | Q34651031 | ||
| Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study | Q34674680 | ||
| A clinical genetic method to identify mechanisms by which pain causes depression and anxiety. | Q34715898 | ||
| Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene | Q34902609 | ||
| The mu-opioid receptor gene and smoking initiation and nicotine dependence | Q35012142 | ||
| Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence | Q35189955 | ||
| Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene | Q35762035 | ||
| What place does naltrexone have in the treatment of alcoholism? | Q35820303 | ||
| Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene | Q36016764 | ||
| Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis | Q36050631 | ||
| How individual sensitivity to opiates can be predicted by gene analyses | Q36145129 | ||
| mu opiate receptor: cDNA cloning and expression | Q36641338 | ||
| Nicotine abstinence-induced cerebral blood flow changes by genotype | Q36776193 | ||
| Association of candidate genes with antisocial drug dependence in adolescents | Q36952343 | ||
| Initial evidence of an association between OPRM1 and adolescent alcohol misuse | Q36952699 | ||
| The mu opioid receptor A118G gene polymorphism moderates effects of trait anger-out on acute pain sensitivity | Q37037939 | ||
| Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions | Q37140009 | ||
| Genetic variability of the mu-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women | Q37158552 | ||
| OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach | Q37185125 | ||
| Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior | Q37250051 | ||
| Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain | Q37259162 | ||
| Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood | Q37280300 | ||
| Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network | Q37311980 | ||
| Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection | Q37329591 | ||
| Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment | Q37344738 | ||
| Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial | Q37351522 | ||
| Do genetic predictors of pain sensitivity associate with persistent widespread pain? | Q37382439 | ||
| Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment | Q37580433 | ||
| Cloning and pharmacological characterization of a rat mu opioid receptor | Q38314662 | ||
| Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief. | Q39329852 | ||
| Population-specific effects of the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1) on HPA-axis activation | Q44336855 | ||
| A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin | Q44337414 | ||
| A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides | Q44337737 | ||
| Effects of fentanyl on gastric myoelectrical activity: a possible association with polymorphisms of the mu-opioid receptor gene? | Q44338482 | ||
| Association between mu-opioid receptor-1 102T>C polymorphism and intermediate type 2 diabetes phenotypes: results from the Quebec Family Study (QFS). | Q44338984 | ||
| Lack of association of a single-nucleotide polymorphism of the mu-opioid receptor gene with anxiety-related traits: results from a cross-sectional study of adults and a longitudinal study of children. | Q44339302 | ||
| RETRACTED: Association of mu-opioid receptor subunit gene and idiopathic generalized epilepsy | Q44339329 | ||
| Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment | Q44339701 | ||
| A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia | Q44339910 | ||
| A micro opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients | Q44340139 | ||
| Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes. | Q44340286 | ||
| Association of morphine-induced antinociception with variations in the 5' flanking and 3' untranslated regions of the mu opioid receptor gene in 10 inbred mouse strains | Q44340414 | ||
| Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). | Q44340730 | ||
| Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females*. | Q44340770 | ||
| Introducing a new recruitment approach to sample collection for genetic association studies in opioid dependence | Q44340859 | ||
| Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations | Q44340982 | ||
| A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain | Q44341121 | ||
| A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients | Q44341917 | ||
| Association of polymorphism in the human mu-opioid receptor OPRM1 gene with proinflammatory cytokine levels and health perception | Q44342193 | ||
| Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction | Q44342438 | ||
| A genetic association study of the mu opioid receptor and severe opioid dependence | Q44342768 | ||
| Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: a pharmacokinetic-pharmacodynamic study | Q44343433 | ||
| Mu opioid receptor gene polymorphism and neuroleptic-induced tardive dyskinesia in patients with schizophrenia | Q44343563 | ||
| Loss of nicotine-induced behavioral sensitization in micro-opioid receptor knockout mice | Q44343994 | ||
| Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. | Q44344319 | ||
| mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion. | Q44344541 | ||
| The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial | Q44344781 | ||
| Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden | Q44344913 | ||
| Mu opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics | Q44345313 | ||
| Association study of personality factors and the Asn40Asp polymorphism at the mu-opioid receptor gene (OPRM1). | Q44345618 | ||
| Association of functional opioid receptor genotypes with alcohol dependence in Koreans | Q44346071 | ||
| The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease | Q44347117 | ||
| Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden | Q44347200 | ||
| Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence | Q44347354 | ||
| Mu opioid receptor gene variants: lack of association with alcohol dependence | Q44347504 | ||
| A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans | Q44347594 | ||
| Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. | Q44348189 | ||
| The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans | Q44348360 | ||
| mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality | Q44348420 | ||
| Association of polymorphisms in nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4), mu-opioid receptor gene (OPRM1), and ethanol-metabolizing enzyme genes with alcoholism in Korean patients | Q44349048 | ||
| Characterization of the 3' untranslated region of the human mu-opioid receptor (MOR-1) mRNA. | Q44350206 | ||
| Association of the mu-opioid receptor gene with type 2 diabetes mellitus in an African American population | Q44350314 | ||
| The porcine mu opioid receptor: molecular cloning and mRNA distribution in lymphoid tissues | Q44350566 | ||
| Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis | Q44351470 | ||
| Anger regulation style, postoperative pain, and relationship to the A118G mu opioid receptor gene polymorphism: a preliminary study | Q44351528 | ||
| Linkage disequilibrium and association with methamphetamine dependence/psychosis of mu-opioid receptor gene polymorphisms. | Q44351548 | ||
| Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers | Q44351630 | ||
| mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal | Q44352311 | ||
| Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects | Q44352947 | ||
| Sequence Variability and Candidate Gene Analysis in Two Cancer Patients with Complex Clinical Outcomes During Morphine Therapy | Q44403651 | ||
| Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population | Q39342490 | ||
| Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy | Q39348026 | ||
| Association of the mu-opioid receptor gene with smoking cessation | Q40251616 | ||
| Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. | Q40392922 | ||
| Immunohistochemical study of the expression of exon11-containing mu opioid receptor variants in mouse brain | Q40533852 | ||
| Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor | Q40566502 | ||
| Adrenocorticotropin responses to naloxone in sons of alcohol-dependent men. | Q40827257 | ||
| Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence | Q40913413 | ||
| Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
| Cocaine, dopamine and the endogenous opioid system | Q41243604 | ||
| The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference | Q42126097 | ||
| Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial | Q42636195 | ||
| Observational study of the effect of mu-opioid receptor genetic polymorphism on intrathecal opioid labor analgesia and post-cesarean delivery analgesia. | Q43155752 | ||
| Association of human micro-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients | Q43225221 | ||
| Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery | Q43269189 | ||
| Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery | Q43270791 | ||
| Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice | Q43567780 | ||
| Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals | Q43719684 | ||
| Predicting treatment response to naltrexone: the influence of craving and family history | Q43752726 | ||
| The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade | Q43829059 | ||
| The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine | Q43843765 | ||
| A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances | Q43882794 | ||
| Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice | Q43937577 | ||
| Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin | Q43947676 | ||
| Adrenocorticotropin and cortisol responses to a naloxone challenge and risk of alcoholism | Q43960583 | ||
| Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism | Q43991017 | ||
| OPRM1 gene is associated with BMI in Uyghur population | Q44035784 | ||
| Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice. | Q44050781 | ||
| Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity? | Q44161387 | ||
| Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice. | Q44282777 | ||
| Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers | Q44289543 | ||
| Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population | Q44330319 | ||
| Intracisternal A-particle element in the 3' noncoding region of the mu-opioid receptor gene in CXBK mice: a new genetic mechanism underlying differences in opioid sensitivity | Q44330465 | ||
| Genetic variation of the human mu-opioid receptor and susceptibility to idiopathic absence epilepsy | Q44330504 | ||
| Immunohistochemical labeling of the mu opioid receptor carboxy terminal splice variant mMOR-1B4 in the mouse central nervous system | Q44331040 | ||
| Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty | Q44331545 | ||
| The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and protects against respiratory depression in homozygous carriers | Q44331665 | ||
| A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain | Q44332189 | ||
| No association of single nucleotide polymorphisms in the micro-opioid receptor subunit gene with idiopathic generalized epilepsy | Q44332505 | ||
| The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers | Q44333481 | ||
| The opioid system in alcohol and drug dependence: family-based association study | Q44335036 | ||
| Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts | Q44335420 | ||
| Pharmacologic profile of NPC 168 (naltrexone phenyl oxime), a novel compound with activity at opioid receptors | Q44336603 | ||
| Polymorphisms of mu and delta opioid receptor genes and tardive dyskinesia in patients with schizophrenia | Q44336701 | ||
| P433 | issue | 9 | |
| P921 | main subject | opioid | Q427523 |
| pharmacogenomics | Q1152227 | ||
| P304 | page(s) | 1305-1320 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Pharmacogenomics | Q15724625 |
| P1476 | title | Pharmacogenomics of the human µ-opioid receptor | |
| P478 | volume | 12 |
| Q36441533 | ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics |
| Q28088630 | Anesthetic use in newborn infants: the urgent need for rigorous evaluation |
| Q39156065 | Association Between Polymorphisms in the Purinergic P2Y12 Receptor Gene and Severity of Both Cancer Pain and Postoperative Pain. |
| Q39422188 | Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder |
| Q34935818 | Association between genetic polymorphisms in Ca(v)2.3 (R-type) Ca2+ channels and fentanyl sensitivity in patients undergoing painful cosmetic surgery |
| Q44138508 | Association between the A107V substitution in the δ-opioid receptors and ethanol drinking in mice selected for high and low analgesia |
| Q39034167 | Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma |
| Q44345058 | Association of μ-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting |
| Q35854383 | CGRP 4218T/C polymorphism correlated with postoperative analgesic effect of fentanyl |
| Q91559669 | Candidate gene analyses for acute pain and morphine analgesia after pediatric day surgery: African American versus European Caucasian ancestry and dose prediction limits |
| Q38672362 | Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer |
| Q36062073 | Does Opioid Use Cause Angiogenesis and Metastasis? |
| Q34695004 | Haplotypes of P2RX7 gene polymorphisms are associated with both cold pain sensitivity and analgesic effect of fentanyl |
| Q44348860 | In Vitro Chondrotoxicity of Nonsteroidal Anti-inflammatory Drugs and Opioid Medications |
| Q99415640 | Long non-coding RNA MIR4300HG polymorphisms are associated with postoperative nausea and vomiting: a genome-wide association study |
| Q90714102 | Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone |
| Q40636095 | Nociceptin/orphanin FQ receptor gene variation is associated with smoking status in Japanese |
| Q38104745 | OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis |
| Q42604309 | On the role of genetic testing for personalized drug overdose management |
| Q38330216 | Pharmacogenetics of chemotherapy-induced nausea and vomiting |
| Q44334859 | Polymorphism of A118G in μ-opioid receptor gene is associated with risk of esophageal squamous cell carcinoma in a Chinese population |
| Q36773493 | The correlation between post-operative fentanyl requirements and μ-opioid receptor gene A118G polymorphism in patients undergoing radical gastrectomy |
| Q36926952 | Transforming pain medicine: adapting to science and society |
| Q52349592 | When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children. |
| Q35929381 | μ-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer |
Search more.